Patent · US Active

Production of megakaryoctye compositions and therapies for treatment of thrombocytopenia

US11713447B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2017
Grant dateAug 1, 2023
Priority date—
Expiry dateAug 5, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to production of megakaryocyte (MK) compositions and their the treatment of thrombocytopenia in a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.